These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 17042914

  • 1. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, reduces infarction volume and neurological deficits in an embolic model of stroke.
    Allahtavakoli M, Shabanzadeh AP, Sadr SS, Parviz M, Djahanguiri B.
    Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1052-8. PubMed ID: 17042914
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat.
    Allahtavakoli M, Moloudi R, Arababadi MK, Shamsizadeh A, Javanmardi K.
    Brain Res; 2009 May 19; 1271():121-7. PubMed ID: 19332033
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Peroxisome proliferator-activated receptor-gamma ligands reduce inflammation and infarction size in transient focal ischemia.
    Sundararajan S, Gamboa JL, Victor NA, Wanderi EW, Lust WD, Landreth GE.
    Neuroscience; 2005 May 19; 130(3):685-96. PubMed ID: 15590152
    [Abstract] [Full Text] [Related]

  • 6. Rosiglitazone alone or in combination with tissue plasminogen activator improves ischemic brain injury in an embolic model in rats.
    Wang CX, Ding X, Noor R, Pegg C, He C, Shuaib A.
    J Cereb Blood Flow Metab; 2009 Oct 19; 29(10):1683-94. PubMed ID: 19553906
    [Abstract] [Full Text] [Related]

  • 7. Neuroprotection by rosiglitazone in transient focal cerebral ischemia might not be mediated by glutamate transporter-1.
    Verma R, Mishra V, Gupta K, Sasmal D, Raghubir R.
    J Neurosci Res; 2011 Nov 19; 89(11):1849-58. PubMed ID: 21826699
    [Abstract] [Full Text] [Related]

  • 8. Peroxisome proliferator-activated receptorsgamma (PPARgamma) differently modulate the interleukin-6 expression in the peri-infarct cortical tissue in the acute and delayed phases of cerebral ischaemia.
    Patzer A, Zhao Y, Stöck I, Gohlke P, Herdegen T, Culman J.
    Eur J Neurosci; 2008 Nov 19; 28(9):1786-94. PubMed ID: 18973594
    [Abstract] [Full Text] [Related]

  • 9. Altered PPARgamma expression and activation after transient focal ischemia in rats.
    Victor NA, Wanderi EW, Gamboa J, Zhao X, Aronowski J, Deininger K, Lust WD, Landreth GE, Sundararajan S.
    Eur J Neurosci; 2006 Sep 19; 24(6):1653-63. PubMed ID: 17004929
    [Abstract] [Full Text] [Related]

  • 10. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
    Legos JJ, Lenhard SC, Haimbach RE, Schaeffer TR, Bentley RG, McVey MJ, Chandra S, Irving EA, Andrew A Parsons, Barone FC.
    Exp Neurol; 2008 Jul 19; 212(1):53-62. PubMed ID: 18462720
    [Abstract] [Full Text] [Related]

  • 11. The intracerebral application of the PPARgamma-ligand pioglitazone confers neuroprotection against focal ischaemia in the rat brain.
    Zhao Y, Patzer A, Gohlke P, Herdegen T, Culman J.
    Eur J Neurosci; 2005 Jul 19; 22(1):278-82. PubMed ID: 16029218
    [Abstract] [Full Text] [Related]

  • 12. Neuroprotective effects of prostaglandin A(1) in rat models of permanent focal cerebral ischemia are associated with nuclear factor-kappaB inhibition and peroxisome proliferator-activated receptor-gamma up-regulation.
    Zhang HL, Gu ZL, Savitz SI, Han F, Fukunaga K, Qin ZH.
    J Neurosci Res; 2008 Apr 19; 86(5):1132-41. PubMed ID: 18074385
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Rosiglitazone and PPAR-gamma overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins.
    Wu JS, Lin TN, Wu KK.
    J Cell Physiol; 2009 Jul 19; 220(1):58-71. PubMed ID: 19229877
    [Abstract] [Full Text] [Related]

  • 16. Different effect of acute treatment with rosiglitazone on rat myocardial ischemia/reperfusion injury by administration method.
    Abe M, Takiguchi Y, Ichimaru S, Kaji S, Tsuchiya K, Wada K.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):215-9. PubMed ID: 18571644
    [Abstract] [Full Text] [Related]

  • 17. Peroxisome proliferator-activated receptor gamma agonist improves arterial stiffness in patients with type 2 diabetes mellitus and coronary artery disease.
    Yu J, Jin N, Wang G, Zhang F, Mao J, Wang X.
    Metabolism; 2007 Oct 28; 56(10):1396-401. PubMed ID: 17884451
    [Abstract] [Full Text] [Related]

  • 18. Use of peroxisome proliferator-activated receptor gamma agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial.
    Boggild AK, Krudsood S, Patel SN, Serghides L, Tangpukdee N, Katz K, Wilairatana P, Liles WC, Looareesuwan S, Kain KC.
    Clin Infect Dis; 2009 Sep 15; 49(6):841-9. PubMed ID: 19673614
    [Abstract] [Full Text] [Related]

  • 19. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
    Lin MS, Chen WC, Bai X, Wang YD.
    J Dig Dis; 2007 May 15; 8(2):82-8. PubMed ID: 17532820
    [Abstract] [Full Text] [Related]

  • 20. Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis.
    Koufany M, Moulin D, Bianchi A, Muresan M, Sebillaud S, Netter P, Weryha G, Jouzeau JY.
    Arthritis Res Ther; 2008 May 15; 10(1):R6. PubMed ID: 18199331
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.